Ionic Capital Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Ionic Capital Management’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-77,066	Closed	-$374K	–	387
2021 Q2	$374K	Hold	77,066	–	–	0.04%	267
2021 Q1	$218K	Hold	77,066	–	–	0.03%	243
2020 Q4	$90K	Hold	77,066	–	–	0.01%	217
2020 Q3	$64K	Hold	77,066	–	–	0.01%	197
2020 Q2	$79K	Hold	77,066	–	–	0.02%	202
2020 Q1	$72K	Buy	+77,066	New	+$61.5K	0.06%	99

Other funds holding PAVMZ

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ionic Capital Management's PAVMZ Position: Q3 2021 in Review

Ionic Capital Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q3 2021, closing a stake of 77,066 shares — an estimated $374K sold.

Ionic Capital Management first reported a position in PAVMZ in Q1 2020 and held it in 6 quarters. The position peaked at $374K in Q2 2021. 8 funds tracked by Wall St. Rank hold PAVMZ as of Q3 2021.

Ionic Capital Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q3 2021 after selling out during the quarter.
Ionic Capital Management sold 77,066 PAVmed Inc. Series Z Warrant shares in Q3 2021, an estimated $374K.
Ionic Capital Management first reported a position in PAVmed Inc. Series Z Warrant in Q1 2020 and held it in 6 quarters.
Ionic Capital Management's PAVmed Inc. Series Z Warrant position peaked at $374K in Q2 2021.
8 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q3 2021.

Based on Ionic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.